These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26952039)

  • 41. Sunitinib modulates the radiosensitivity of esophageal squamous cell carcinoma cells in vitro.
    Ding YQ; Zhu HC; Chen XC; Sun XC; Yang X; Qin Q; Zhang H; Yang Y; Yang YH; Gao L; Luo JD; Zhou XF
    Dis Esophagus; 2016 Nov; 29(8):1144-1151. PubMed ID: 26542732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carcinostatic effects of platinum nanocolloid combined with gamma irradiation on human esophageal squamous cell carcinoma.
    Li Q; Tanaka Y; Saitoh Y; Tanaka H; Miwa N
    Life Sci; 2015 Apr; 127():106-14. PubMed ID: 25711430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy.
    Fu G; Somasundaram RT; Jessa F; Srivastava G; MacMillan C; Witterick I; Walfish PG; Ralhan R
    Oncotarget; 2016 Mar; 7(13):17162-81. PubMed ID: 26934445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia.
    Kannan S; Aitken MJL; Herbrich SM; Golfman LS; Hall MG; Mak DH; Burks JK; Song G; Konopleva M; Mullighan CG; Chandra J; Zweidler-McKay PA
    Mol Cancer Ther; 2019 Sep; 18(9):1615-1627. PubMed ID: 31227645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiation-induced autophagy promotes esophageal squamous cell carcinoma cell survival via the LKB1 pathway.
    Lu C; Xie C
    Oncol Rep; 2016 Jun; 35(6):3559-65. PubMed ID: 27109915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair.
    Qin Q; Cheng H; Lu J; Zhan L; Zheng J; Cai J; Yang X; Xu L; Zhu H; Zhang C; Liu J; Ma J; Zhang X; Dai S; Sun X
    J Hematol Oncol; 2014 Aug; 7():62. PubMed ID: 25139395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PLK1 Inhibition Radiosensitizes Breast Cancer Cells, but Shows Low Efficacy as Monotherapy or in Combination with other Cytotoxic Drugs.
    Brassesco MS; Pezuk JA; Salomão KB; Roberto GM; Scrideli CA; Tone LG
    Anticancer Agents Med Chem; 2018; 18(9):1252-1257. PubMed ID: 29493466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells.
    Zhan L; Qin Q; Lu J; Liu J; Zhu H; Yang X; Zhang C; Xu L; Liu Z; Cai J; Ma J; Dai S; Tao G; Cheng H; Sun X
    Dis Esophagus; 2016 Apr; 29(3):215-23. PubMed ID: 25604309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma.
    Yousef EH; El-Mesery ME; Habeeb MR; Eissa LA
    Tumour Biol; 2020 Apr; 42(4):1010428320914475. PubMed ID: 32252611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current clinical trials with polo-like kinase 1 inhibitors in solid tumors.
    Yim H
    Anticancer Drugs; 2013 Nov; 24(10):999-1006. PubMed ID: 23949254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma.
    Li Y; Zhao ZG; Luo Y; Cui H; Wang HY; Jia YF; Gao YT
    World J Gastroenterol; 2020 Aug; 26(32):4786-4801. PubMed ID: 32921957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eribulin synergizes with Polo-like kinase 1 inhibitors to induce apoptosis in rhabdomyosarcoma.
    Stehle A; Hugle M; Fulda S
    Cancer Lett; 2015 Aug; 365(1):37-46. PubMed ID: 25917079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
    Lian G; Li L; Shi Y; Jing C; Liu J; Guo X; Zhang Q; Dai T; Ye F; Wang Y; Chen M
    Int J Oncol; 2018 Mar; 52(3):804-814. PubMed ID: 29393385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibiting polo-like kinase 1 enhances radiosensitization via modulating DNA repair proteins in non-small-cell lung cancer.
    Yao D; Gu P; Wang Y; Luo W; Chi H; Ge J; Qian Y
    Biochem Cell Biol; 2018 Jun; 96(3):317-325. PubMed ID: 29040814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The polo-like kinase inhibitor BI 2536 exhibits potent activity against malignant plasma cells and represents a novel therapy in multiple myeloma.
    Stewart HJ; Kishikova L; Powell FL; Wheatley SP; Chevassut TJ
    Exp Hematol; 2011 Mar; 39(3):330-8. PubMed ID: 21184800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
    Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
    Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest.
    Qian X; Tan C; Yang B; Wang F; Ge Y; Guan Z; Cai J
    Dis Esophagus; 2017 Jun; 30(6):1-7. PubMed ID: 28475750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma.
    Pezuk JA; Brassesco MS; Morales AG; de Oliveira JC; de Paula Queiroz RG; Machado HR; Carlotti CG; Neder L; Scrideli CA; Tone LG
    Cancer Gene Ther; 2013 Sep; 20(9):499-506. PubMed ID: 23887645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
    Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
    Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways.
    Akimoto T; Nonaka T; Ishikawa H; Sakurai H; Saitoh JI; Takahashi T; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):195-201. PubMed ID: 11316564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.